218 related articles for article (PubMed ID: 8973755)
1. Tissue-specific regulation of angiotensin-converting enzyme by angiotensin II and losartan in the rat.
Metsärinne KP; Helin KH; Saijonmaa O; Stewen P; Sirviö ML; Fyhrquist FY
Blood Press; 1996 Nov; 5(6):363-70. PubMed ID: 8973755
[TBL] [Abstract][Full Text] [Related]
2. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.
Campbell DJ; Kladis A; Valentijn AJ
J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048
[TBL] [Abstract][Full Text] [Related]
3. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
Haddad G; Amiri F; Garcia R
Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
[TBL] [Abstract][Full Text] [Related]
4. Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload.
Ishiye M; Umemura K; Uematsu T; Nakashima M
Biol Pharm Bull; 1995 May; 18(5):700-4. PubMed ID: 7492986
[TBL] [Abstract][Full Text] [Related]
5. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
[TBL] [Abstract][Full Text] [Related]
7. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
Mizuno K; Tani M; Hashimoto S; Niimura S; Sanada H; Watanabe H; Ohtsuki M; Fukuchi S
Life Sci; 1992; 51(5):367-74. PubMed ID: 1385640
[TBL] [Abstract][Full Text] [Related]
8. Effect of losartan on right ventricular hypertrophy and cardiac angiotensin I-converting enzyme activity in pulmonary hypertensive rats.
Kreutz R; Fernandez-Alfonso MS; Ganten D; Paul M
Clin Exp Hypertens; 1996 Jan; 18(1):101-11. PubMed ID: 8822237
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated.
van Kleef EM; Fingerle J; Daemen MJ
Arterioscler Thromb Vasc Biol; 1996 Jul; 16(7):857-63. PubMed ID: 8673560
[TBL] [Abstract][Full Text] [Related]
11. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
[TBL] [Abstract][Full Text] [Related]
12. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
Leenen FH; White R; Yuan B
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2410-6. PubMed ID: 11709406
[TBL] [Abstract][Full Text] [Related]
13. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
Wada T; Inada Y; Ojima M; Sanada T; Shibouta Y; Nishikawa K
Hypertens Res; 1996 Jun; 19(2):75-81. PubMed ID: 10968199
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Ca2+ modulation by angiotensin II and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats.
Touyz RM; Fareh J; Thibault G; Schiffrin EL
Hypertension; 1996 Nov; 28(5):797-805. PubMed ID: 8901826
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic central administration of losartan on the cardiovascular and hormonal responses to hemorrhage in conscious rats.
Yang EK; Lee WJ; Park YY; Ahn DK; Park JS; Kim HJ
Regul Pept; 1996 Dec; 67(2):107-13. PubMed ID: 8958581
[TBL] [Abstract][Full Text] [Related]
18. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats.
Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA
Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683
[TBL] [Abstract][Full Text] [Related]
19. Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent.
Lombardi DM; Viswanathan M; Vio CP; Saavedra JM; Schwartz SM; Johnson RJ
Nephron; 2001 Jan; 87(1):66-74. PubMed ID: 11174028
[TBL] [Abstract][Full Text] [Related]
20. Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries.
Kauffman RF; Bean JS; Zimmerman KM; Brown RF; Steinberg MI
Life Sci; 1991; 49(25):PL223-8. PubMed ID: 1745100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
